BGB Group Appoints Fred Bennett As Chief Digital Officer
BGB group, a healthcare advertising, medical education, and strategic consulting agency, announced that Fred Bennett has been named as the firm’s first-ever Chief Digital Officer (CDO).
In his role, Fred will focus on leading and managing the digital teams within BGB Group and strengthening the agency’s long-term plan for leveraging new technologies, innovation, and customer insights to meet client needs in the healthcare industry. Reporting to the agency’s Managing Partners, the CDO will be a key member of the BGB Group executive team.
Continue reading here.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Asembia 2025: Therapy Advancements Highlight Growing Cost and Access Concerns
April 30th 2025Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.
